Authors' reply

Gut

Volumn 58, Issue 6, 2009, Pages 883-884

  Simms, L A ^a   Doecke, J D ^b   Radford Smith, G L ^c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b CSIRO   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15;

CROHN DISEASE; ENTERITIS; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 66649117701     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53:1658-1664 (Pubitemid 39434112)
2. Wehkamp J, Salzman NK, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005;102:18129-18134 (Pubitemid 41798513)
3. Simms LA, Doecke JD, Walsh MD, et al. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008;57:903-910
4. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2- dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-734 (Pubitemid 40194644)
5. Swidsinski A, Loening-Baucke V, Bengmark S, et al. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis. Inflamm Bowel Dis 2007;13:51-56 (Pubitemid 46080009)
6. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-521 (Pubitemid 46348505)